Top Markets
Coin of the day
InNexus Biotechnology, Inc. InNexus Biotechnology, Inc.

InNexus Biotechnology, Inc.

IXSBF
Κατάταξη σε μετοχές #41696
InNexus Biotechnology, Inc. is a development-stage company dedicated to... InNexus Biotechnology, Inc. is a development-stage company dedicated to advancing and commercializing monoclonal antibodies. Its efforts are underpinned by its proprietary Dynamic Cross Linking (DXL) technology. This DXL platform is designed to boost the therapeutic efficacy of conventional monoclonal antibody treatments by strengthening their binding to target antigens, amplifying their effector functions, and endowing them with novel properties. InNexus's development portfolio features several investigational therapies: DXL625: A monoclonal antibody currently in late-stage pre-clinical development, engineered for superior binding kinetics and enhanced effector functions, intended for treating B-cell non-Hodgkin's lymphoma (NHL). DXLr120: A recombinant DXL anti-CD20 antibody also being developed for B-cell NHL. DXL702: A monoclonal antibody targeting metastatic breast cancer. DXL1218: An agent designed to target the epidermal growth factor receptor (EGFR), an antigen frequently overexpressed in metastatic colorectal cancer and squamous cell carcinomas of the head and neck. The company also maintains strategic partnerships with XERIS Pharmaceuticals, Genhelix, Evogenix, Affimed, and Corixa. InNexus Biotechnology, Inc. is based in Vancouver, Canada.
Τιμή μετοχής
$0.0001
Τελευταίος συγχρονισμός: 2025-11-07
Κεφαλαιοποίηση
$12.63K
Αλλαγή (1 ημέρα)
0.00%
Αλλαγή (1 έτος)
0.00%
Χώρα
CA
Εμπόριο InNexus Biotechnology, Inc. (IXSBF)

Κατηγορία

Ιστορικό τιμής μετοχής για την InNexus Biotechnology, Inc. (IXSBF)
Υψηλότερη τιμή κλεισίματος: $0.00 στις 2025-11-01

Χαμηλότερη τιμή κλεισίματος: $0.54 στις 2005-01-01
Ιστορικό τιμής μετοχής της InNexus Biotechnology, Inc. από 2005 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2026 (TTM) 0.00%
2025 0.00%
2024 9,900.00%
2023 -98.02%
2022 -49.50%
2021 809.09%
2020 1,000.00%
2019 -99.00%
2018 0.00%
2017 0.00%
2016 20.00%
2015 -89.80%
2014 45.43%
2013 -9.43%
2012 -75.12%
2011 -93.68%
2010 -30.02%
2009 -1.01%
2008 -76.04%
2007 -65.32%
2006 182.90%
2005 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
$59.08 62.03%
US
$49.68 72.21%
SE
$184.45 43.36%
FR
$62.39 4.91%
IT
$113.04 55.27%
US